Fragile Bone disease is a killer, but avoidable if caught early

1 in 2 women and 1 in 5 men over the age of 50 in the UK will fracture a bone due to deteriorating bone health. Known as Osteoperosis, this disease has been expensive to diagnose, until now.

This condition is caused by a decline in the mineral density of the bones of the body, which become weak and fragile and more likely to break or fracture. Over 3 million people in the UK are thought to have osteoporosis, resulting in over 230,000 fractures every year. Despite this, most diagnoses take place after a bone has already broken, often too late for elderly patients.

An early diagnosis of Osteoporosis can make a huge difference to the quality of life of a patient, but until now, diagnosing the condition has been an expensive process involving a trip to the hospital and a specialist ‘DEXA Scan’.

CrescentDiagnostics, after many years of equity funded research, has established a link between the protein Keratin in the nail and bone health and has developed an Osteoporosis screening test, which has been successfully tested and their patented testing kits, called Osentia are already available. The sample (a nail clipping) is taken at home and posted to an accredited laboratory. The result is returned within three days and you simply show it to your doctor if the result is positive.

Funding is required to roll out the tests across the market place.

By Simon Heywood,